An echocardiogram is a non-invasive medical test that utilizes high-frequency sound waves, or ultrasound, to create detailed images of the heart's structure and function. This diagnostic tool plays a crucial role in assessing the health of the heart and identifying various cardiac conditions. During an echocardiogram, a transducer is placed on the chest, emitting sound waves that bounce off the heart's tissues and create real-time images displayed on a monitor. This imaging technique allows healthcare professionals to visualize the heart's chambers, valves, and blood flow patterns, providing valuable information about cardiac anatomy and function. Echocardiograms are commonly used to diagnose conditions such as heart valve disorders, cardiomyopathies, and congenital heart defects. Additionally, they assist in monitoring the effectiveness of treatments and interventions, guiding medical professionals in formulating personalized and effective care plans for individuals with heart-related concerns. The non-invasiveness and ability to obtain real-time images make echocardiograms a vital tool in the field of cardiology, contributing significantly to the comprehensive evaluation of cardiac health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India